Gino Santini

Gino has served on the board of directors since March 2012. He currently serves as the chairman of the board of directors of AMAG Pharmaceuticals, Inc. and is onthe board of directors of Intercept Pharmaceuticals and Collegium Pharmaceuticals, and is retired from a distinguished career with Eli Lilly and Company that spanned nearly three decades. Gino previously served on the board of directors for Sorin SpA from 2012 to 2015, when it was acquired by LivaNova plc. He capped his career at Lilly as a member of the company’s executive committee and as the senior vice president of corporate strategy and business development.

Gino holds a degree in mechanical engineering from the University of Bologna and a Master of Business Administration from the University of Rochester.